Jul 15, 2024 21:00
ALKS - Alkermes Inc. plc
Day | 1m | 10m | 60m | PreMarket | Market | AfterHours | Gap |
---|---|---|---|---|---|---|---|
33.09 -0.86 (-2.6%) | --- | --- | --- | 0.88 (2.66%) | 0.72 (2.28%) | --- | 0.88 (2.66%) |
Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.
Earnings & Ratios
- Basic EPS:
- 0.53
- Diluted EPS:
- 0.52
- Basic P/E:
- 60.8113
- Diluted P/E:
- 61.9808
- RSI(14) 1m:
- 63.22
- VWAP:
- 32.22
- RVol:
- 0.5208
Events
Period | Kind | Movement | Occurred At |
---|---|---|---|
1m | Price increase 1m | 33.97 +0.88 (+2.66%) | Oct 15 05:04 |
Related News
Jun 24, 2024 12:07
May 31, 2024 15:31
May 27, 2024 10:20
May 23, 2024 16:00
May 21, 2024 12:48
May 02, 2024 18:00
May 02, 2024 15:39
May 01, 2024 13:30
May 01, 2024 12:30